Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Sutro Biopharma Inc.

    NASDAQ: STRO · Real-Time Price · USD
    0.87
    0.07 (8.87%)
    At close: Jun 16, 2025, 3:59 PM
    0.85
    -2.34%
    Pre-market: Jun 17, 2025, 04:24 AM EDT

    Sutro Biopharma Statistics

    Share Statistics

    Sutro Biopharma has 84.46M shares outstanding. The number of shares has increased by 2.42% in one year.

    Shares Outstanding

    n/a
    		 84.46M

    Shares Change (YoY)

    n/a
    		 2.42%

    Shares Change (QoQ)

    n/a
    		 1.6%

    Owned by Institutions (%)

    n/a
    		 77.88%

    Shares Floating

    n/a
    		 78.04M

    Failed to Deliver (FTD) Shares

    n/a
    		 55,486

    FTD / Avg. Volume

    n/a
    		 3.36%

    Short Selling Information

    The latest short interest is 5.63M, so 6.67% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 5.63M

    Short % of Shares Out

    n/a
    		 6.67%

    Short % of Float

    n/a
    		 6.71%

    Short Ratio (days to cover)

    n/a
    		 7.35

    Valuation Ratios

    The PE ratio is -0.62 and the forward PE ratio is -0.8. Sutro Biopharma's PEG ratio is -0.01.

    PE Ratio

    n/a
    		 -0.62

    Forward PE

    n/a
    		 -0.8

    PS Ratio

    n/a
    		 2.28

    Forward PS

    n/a
    		 1.1

    PB Ratio

    n/a
    		 3.17

    P/FCF Ratio

    n/a
    		 -0.73

    PEG Ratio

    n/a
    		 -0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Sutro Biopharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.6, with a Debt / Equity ratio of 0.52.

    Current Ratio

    n/a
    		 2.6

    Quick Ratio

    n/a
    		 2.6

    Debt / Equity

    n/a
    		 0.52

    Debt / EBITDA

    n/a
    		 -0.13

    Debt / FCF

    n/a
    		 -0.12

    Interest Coverage

    n/a
    		 -7.67

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $230,643.12

    Profits Per Employee

    n/a
    		 $-845,579.93

    Employee Count

    n/a
    		 269

    Asset Turnover

    n/a
    		 0.16

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 2.36M

    Effective Tax Rate

    n/a
    		 -1.05%

    Stock Price Statistics

    The stock price has increased by -72.81% in the last 52 weeks. The beta is 1.71, so Sutro Biopharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.71

    52-Week Price Change

    n/a
    		 -72.81%

    50-Day Moving Average

    n/a
    		 0.84

    200-Day Moving Average

    n/a
    		 2.13

    Relative Strength Index (RSI)

    n/a
    		 51.25

    Average Volume (20 Days)

    n/a
    		 1,653,723

    Income Statement

    In the last 12 months, Sutro Biopharma had revenue of 62.04M and earned -227.46M in profits. Earnings per share was -2.96.

    Revenue

    n/a
    		 62.04M

    Gross Profit

    n/a
    		 54.83M

    Operating Income

    n/a
    		 -238.45M

    Net Income

    n/a
    		 -227.46M

    EBITDA

    n/a
    		 -180.45M

    EBIT

    n/a
    		 -194.03M

    Earnings Per Share (EPS)

    n/a
    		 -2.96
    Full Income Statement

    Balance Sheet

    The company has 190.3M in cash and 23.15M in debt, giving a net cash position of 167.15M.

    Cash & Cash Equivalents

    n/a
    		 190.3M

    Total Debt

    n/a
    		 23.15M

    Net Cash

    n/a
    		 167.15M

    Retained Earnings

    n/a
    		 -786.87M

    Total Assets

    n/a
    		 321.43M

    Working Capital

    n/a
    		 154.36M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -191.54M and capital expenditures -3.1M, giving a free cash flow of -194.64M.

    Operating Cash Flow

    n/a
    		 -191.54M

    Capital Expenditures

    n/a
    		 -3.1M

    Free Cash Flow

    n/a
    		 -194.64M

    FCF Per Share

    n/a
    		 -2.53
    Full Cash Flow Statement

    Margins

    Gross margin is 88.37%, with operating and profit margins of -384.34% and -366.62%.

    Gross Margin

    n/a
    		 88.37%

    Operating Margin

    n/a
    		 -384.34%

    Pretax Margin

    n/a
    		 -362.81%

    Profit Margin

    n/a
    		 -366.62%

    EBITDA Margin

    n/a
    		 -290.85%

    EBIT Margin

    n/a
    		 -384.34%

    FCF Margin

    n/a
    		 -313.71%

    Dividends & Yields

    STRO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for STRO is $2, which is 129.9% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $2

    Price Target Difference

    n/a
    		 129.9%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 7
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -4.98

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist